Supplemental material
Open access
4,799
Views
1
CrossRef citations to date
0
Altmetric
Report
Rapid in vitro assessment of the immunogenicity potential of engineered antibody therapeutics through detection of CD4+ T cell interleukin-2 secretion
Yoshiyuki Arataa Translational Research Division, Chugai Pharmaceutical Co., Ltd, Kanagawa, JapanView further author information
, Shigeki Motoyamab Research Division, Chugai Pharmaceutical Co., Ltd, Kanagawa, JapanView further author information
, Mariko Yanoa Translational Research Division, Chugai Pharmaceutical Co., Ltd, Kanagawa, JapanView further author information
, Tatsuya Ikunoa Translational Research Division, Chugai Pharmaceutical Co., Ltd, Kanagawa, JapanView further author information
, Shunsuke Itoa Translational Research Division, Chugai Pharmaceutical Co., Ltd, Kanagawa, JapanView further author information
, Tomochika Matsushitaa Translational Research Division, Chugai Pharmaceutical Co., Ltd, Kanagawa, JapanView further author information
, Akira Takeiria Translational Research Division, Chugai Pharmaceutical Co., Ltd, Kanagawa, JapanView further author information
, Yukari Nishitoa Translational Research Division, Chugai Pharmaceutical Co., Ltd, Kanagawa, Japan;b Research Division, Chugai Pharmaceutical Co., Ltd, Kanagawa, JapanView further author information
, Nami Yabukib Research Division, Chugai Pharmaceutical Co., Ltd, Kanagawa, JapanView further author information
, Hideaki Mizunob Research Division, Chugai Pharmaceutical Co., Ltd, Kanagawa, JapanView further author information
, Zenjiro Sampeib Research Division, Chugai Pharmaceutical Co., Ltd, Kanagawa, JapanView further author information
, Masayuki Mishimaa Translational Research Division, Chugai Pharmaceutical Co., Ltd, Kanagawa, JapanView further author information
, Masaki Hondaa Translational Research Division, Chugai Pharmaceutical Co., Ltd, Kanagawa, JapanView further author information
, Jumpei Kiyokawaa Translational Research Division, Chugai Pharmaceutical Co., Ltd, Kanagawa, JapanView further author information
, Hiromi Suzukia Translational Research Division, Chugai Pharmaceutical Co., Ltd, Kanagawa, JapanView further author information
, Shuichi Chibaa Translational Research Division, Chugai Pharmaceutical Co., Ltd, Kanagawa, JapanView further author information
, Mitsuyasu Tabob Research Division, Chugai Pharmaceutical Co., Ltd, Kanagawa, JapanView further author information
& Chiyomi Kuboa Translational Research Division, Chugai Pharmaceutical Co., Ltd, Kanagawa, JapanCorrespondence[email protected]
View further author information
show allView further author information
Article: 2253570
|
Received 14 Mar 2023, Accepted 27 Aug 2023, Published online: 08 Sep 2023
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.